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Cytotoxic T-cells (CTL) play a central role in the recovery of mammalian hosts from retroviral infections. However, the molecular
pathways that mediate the antiretroviral activity of CTL are still elusive. Here we explore the protective role of the two main cytolytic
pathways of CTL, that is, granule exocytosis and Fas/Fas ligand (FasL), in acute and persistent Friend retrovirus (FV) infection of mice. For
this purpose, we have used mutant mouse strains with targeted gene defects in one or more components of the two cytolytic pathways
including perforin, granzyme A, granzyme B, Fas, and FasL. The important function of CTL in resistance of C57BL/6 (B6) mice to FV is
emphasized by the finding that depletion of CD8+ T-cells prior to virus infection resulted in severe splenomegaly and high viral loads in
blood and spleen tissue. Analysis of primary FV infection in knockout mice revealed that acute infection was readily controlled in the absence
of functional Fas. Most notably in the presence of Fas/FasL each of the three effector molecules of the exocytosis pathway (i.e., perforin,
granzyme A, and granzyme B) was capable on its own to mediate suppression of virus replication and protection from leukemia. However,
triple knockout mice lacking perforin and the two granzymes were fully susceptible to FV-induced leukemia. In contrast to acute infection the
Fas/FasL pathway was mandatory for effective control of FV replication during persistent infection. These findings suggest novel pathways
of CTL-mediated viral defense and contribute towards a better understanding of the molecular mechanisms of CTL activity in retroviral
infections.
D 2004 Elsevier Inc. All rights reserved.
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The critical role of cytotoxic T-cells (CTL) in the control
of acute viremia in retroviral infections, including HIV and
the simian immunodeficiency virus (SIV), is well appre-
ciated (Buseyne and Riviere, 1993; Letvin et al., 1999). This
also holds true for the recovery of mice from primary
infection with Friend retrovirus (FV) (Hasenkrug and0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.08.040
* Corresponding author. Institut fu¨r Virologie, des Universita¨tsklini-
kums Essen, Hufelandstr. 55, 45122 Essen, Germany. Fax: +49 201 723
5929.
E-mail address: ulf.dittmer@uni-essen.de (U. Dittmer).
1 Both authors contributed equally to this work.Dittmer, 2000). However, so far the detailed molecular
mechanisms by which CTL interfere with retroviral
replication are elusive. Researchers have studied molecular
CTL functions in HIV-infected humans and SIV-infected
monkeys but only correlative data can be obtained from
such experiments (Buseyne and Riviere, 1993; Letvin et al.,
1999). With the current advance in technology to generate
mutant mice with specifically tailored gene deletions
(knockout mice), an in vivo evaluation of the role of
individual CTL effector molecules in the control of
retrovirus infections became possible.
We have used the Friend virus (FV) model to define
molecules that are involved in antiretroviral CTL activity.
FV is a retroviral complex comprised of a replication-04) 365–374
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virus (F-MuLV), which is nonpathogenic in adult mice and a
replication-defective but pathogenic virus, spleen focus
forming virus (SFFV) (Kabat, 1989). SFFV encodes a
defective envelope protein that binds to the erythropoietin
receptor leading to polyclonal proliferation of Ter119-
positive erythroblasts. The infection of adult mice with FV
induces acute viremia and splenomegaly of varying degrees
depending on the genetic background of the mouse strain
(Chesebro et al., 1990; Hasenkrug, 1999). In susceptible
strains, disease progresses to lethal erythroleukemia whereas
resistant mice, such as C57BL/6 (B6) mice, control the
erythroblast proliferation. From previous studies, it is
known that both virus-specific humoral and cellular immune
responses, including CD8-positive CTL, are essential for
recovery from primary FV infection (Hasenkrug and
Dittmer, 2000). In the current study, we analyzed the role
of the exocytosis and the Fas pathway in the CTL-mediated
immunity to FV infection using mice with genetic inactiva-
tions. All mice used for these experiments were on the B6
genetic background because of the availability of knockout
mice with one or more genetic defects in perforin (perf),
granzyme A (gzmA), granzyme B (gzmB), Fas (Fas), and
Fas ligand (FasL; gld) expression. When studying FV-
induced disease in B6 mice, one has to consider that they are
genetically resistant to FV-induced erythroleukemia due to
the Fv2 gene. Fv2 acts in a nonimmunological manner to
limit FV-induced polyclonal cell activation (Hoatlin et al.,
1994; Persons et al., 1999). Despite the genetic resistance of
normal B6 mice to FV-induced leukemia, they are not
resistant to infection. FV replicates quite efficiently in B6
mice during acute infection and the mice are unable to
completely eliminate the virus and become persistently
infected (Hasenkrug, 1999). Furthermore, B6 mice deficient
in the CD8+ lymphocyte subset develop a late erythroleu-
kemia (Hasenkrug, 1999; Kitagawa et al., 1986; Van der
Gaag and Axelrad, 1990), indicating that CTL responsive-
ness is an important factor in the resistance of B6 mice to
FV-induced leukemia.
CTL can control viral infections by two cytolytic effector
pathways (Ka¨gi et al., 1994a; Lowin et al., 1994), both of
which lead to apoptosis of infected target cells. The first,
termed the granule exocytose pathway, is mediated by a
concerted action of perf (Henkart, 1994; Podack et al.,
1991) with two serine proteases, that is, gzmA and gzmB
(Simon and Kramer, 1994; Tschopp, 1994). This pathway
was shown to be essential for recovery from many different
virus infections (Balkow et al., 2001; Ka¨gi et al., 1994a;
Mu¨llbacher et al., 1999). The second pathway, designated
the FasL/Fas-mediated pathway, is induced via binding of
the Fas ligand on CTL to the Fas-receptor on infected target
cells. Although this cytolytic pathway was suggested to be
mainly involved in processes of homeostasis and tolerance
(Krammer, 1999; Nagata, 1997; Rouvier et al., 1993), recent
evidence suggests its contribution to antiviral defense
(Balkow et al., 2001; Ka¨gi et al., 1994b; Parra et al.,2000). Studies with perforin-deficient mice provided
unequivocal evidence for perforin as the key element in
recovery from many virus infections, including lymphocytic
choriomeningitis virus (LCMV) (Balkow et al., 2001; Ka¨gi
et al., 1994a; Walsh et al., 1994) and ectromelia virus
(mouse pox virus, Ect) (Mu¨llbacher et al., 1999; Ramshaw
et al., 1997). However, additional experiments with mice
lacking either gzmA and/or gzmB showed that the two gzms
are indispensable effector molecules acting in concert with
perf in recovery from Ect infection (Mu¨llbacher et al., 1999)
or with FasL/Fas in recovery of LCMV infection (Rode and
Simon, personal communication). These studies led to the
assumption that depending on the type of infection, CTL
variably employ perf in combination with different effector
molecules to eliminate a given virus, but apoptosis is a
prerequisite for this endeavor.
Here we analyze the molecular basis for the control of
Friend retrovirus infection by CTL. The current findings
indicate a functional redundancy of the cytoplasmic granula
molecules gzmA, gzmB, and perf as antiviral agents during
acute FV infection. In addition, the data suggest that acute
and chronic retroviral infections are controlled by a distinct
array of CTL effector molecules.Results
CD8+ T-cell responses during acute FV infection contribute
to the resistant phenotype of C57BL/6 mice
C57BL/6 (B6) mice are resistant to FV-induced leukemia
(Persons et al., 1999) but become persistently infected after
FV inoculation (Hasenkrug, 1999). During acute FV
infection, B6 develop a mild and temporary splenomegaly
due to a virus-induced proliferation of Ter119-positive
erythroid precursor cells. Peak viral loads (105–106 infected
centers/spleen) in the spleen of B6 mice are found between
7 and 14 days post-FV infection but infected cells in the
blood are very rare or undetectable (Stromnes et al., 2002).
The initial virus replication is controlled in B6 mice and a
persistent low-level infection (104 infected centers/spleen)
ensues 5 weeks postinfection (Stromnes et al., 2002). It was
previously shown that B6 knockout mice lacking CD8+ T-
cells (B6 CD8 knockouts) develop FV-induced leukemia
during persistent FV infection (Hasenkrug, 1999). To
confirm the critical role of CD8+ T-cells during acute FV
infection, B6 mice were depleted of CD8-positive cells by
antibody treatment starting at the time point of FV infection.
On day 10 post-FV infection, B6 wt mice showed a mild
splenomegaly with a mean spleen weight of 0.36 g (Fig.
1A). In contrast, the spleen weight in FV-infected and CD8-
depleted mice was significantly higher (mean = 0.55 g).
Furthermore the percentage of Ter119-positive erythroid
precursor cells of total spleen cells, another clinical marker
for FV infection, was significantly increased in infected,
CD8-depleted mice (mean = 58.7%) compared to FV-
Fig. 1. Depletion of CD8+ T-cells during acute infection of mice with Friend virus. C57BL/6 mice were infected with FVand depleted for their CD8+ T-cells by
injecting monoclonal antibody169.4. The treatment depleted 83% of the CD8+ cells in the spleen of the animals. Ten days postinfection, the mice were
sacrificed and analyzed for disease progression and viral loads. The results for CD8-depleted, FV-infected animals were compared with those from mice only
infected with FV. Virus-induced disease was documented by spleen weights (A) and the percentage of Ter119-positive erythroid precursor cells in the spleen
(B). Viral loads were measured in the blood (C) and in the spleen (D) of infected mice. Each dot represents the results from a single mouse. The mean value for
each group is indicated by a bar. Differences between the two groups were analyzed by using the Mann–Whitney test. Statistically significant differences
between the groups are given in the figures.
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controls (Fig. 1B). In addition, the number of infected cells
in the blood and spleen was significantly higher after CD8
depletion in comparison to untreated FV-infected mice
(Figs. 1C and D).
Acute FV infection of knockout mice lacking different
cytotoxic molecules
To determine the role of individual cytolytic molecules
in the control of FV, the course of infection was monitored
in mutant mice with singular or multiple defects in perf,
gzms, or Fas. At 10 days postinfection, spleen weights
were measured as a marker for FV-induced disease
(Hasenkrug et al., 1998b) (Fig. 2A). FV-infected B6 wt
mice and all investigated knockout mice (perf/, perf 
gzmA/, perf  gzmB/, gzmA  B/, Fas/, and
gld) except the perf  gzmA  B/ mice showed a mild
and temporary splenomegaly with spleen weights between
0.2 and 0.5 g. In contrast, the mean spleen weight of
infected perf  gzmA  B/ mice (mean 2.33 g) was
greater than six-fold higher than that in the B6 wt control
group (mean 0.37 g), indicating that lack of perf and both
gzms render B6 mice susceptible to the development of
FV-mediated leukemia. As a second marker for disease
FV-mediated proliferation of Ter119-positive erythroid
precursor cells was analyzed. Again infected perf 
gzmA  B/ mice showed the highest percentage of
this particular cell type in the spleen significantly exceed-
ing that in B6 mice and all other mutant mouse strains
(Fig. 2B). Infected knockout mice lacking Fas, FasL, or
gzmA  B had also higher percentages of Ter119-positive
cells in the spleen than B6 wt mice but this difference
reached statistical significance only for the gld (FasL/)
mice. The susceptibility of perf  gzmA  B/ mice to
FV-induced disease was also verified by analyzing viral
loads. A mean of 22.2% of whole blood cells from perf gzmA  B/ mice was virus positive at 10 days post-FV
infection (Fig. 2C). In stark contrast, only a mean of 0.7%
blood cell infection could be detected in the resistant B6
wt mice. Some animals in the group of perf  gzmB/,
gzmA  gzmB/, gld, and Fas/ were slightly positive
for virus detection in the blood but the overall levels of
infection for each group were not significantly different
from the group of B6 wt mice. Similar to blood viral
loads, the mean infection level of spleen cells was 12.3
times higher in perf  gzmA  B/ mice in comparison
to B6 wt animals (Fig. 2D). In contrast, the knockout mice
that were deficient for any two of the three molecules from
the exocytosis pathway did not show enhanced levels of viral
loads compared to B6 wt mice. Slightly enhanced spleen
viral loads were found in mice lacking the Fas/FasL pathway
but the differences to the B6 wt mice did not reach statistical
significance. These results indicate that the exocytosis
pathway is essential for CTL-mediated resistance of B6
mice to FV and that surprisingly only one of the molecules
perf, gzmA, or gzmB was sufficient to mediate the effect.
The spleen viral loads in gld and Fas/ mice were only
slightly enhanced indicating that target cell apoptosis by the
Fas pathway seems to be less important for the control of
acute FV infection in resistant mice.
To exclude the possibility that the increased suscepti-
bility of perf  gzmA  B/ mice to FV infection was due
to an impaired activation or expansion of virus-specific
CD8+ cells, FV-specific splenic CD8+ T-cells were detected
by using the class I tetramer technique. The Db-GagL
tetramers were specific for the H-2Db-restricted, immuno-
dominant gag CTL epitope gPr80gag85-93 (Chen et al.,
1996). At 10 day post-FV infection, a mean of 1.8% of the
CD8+ T-cells from B6 wt mice were positive for Db-GagL
tetramer (Fig. 3A). This percentage of CD8+/tetramer+ T-
cells was higher in the group of perf  gzmA  B/ mice
(mean of 3.5%). In addition, the percentage of CD8+ T-cells
expressing the effector cell marker CD43 was also higher in
Fig. 3. FV-specific CD8+ T-cell response in mice lacking the molecules perforin, granzyme A, and granzyme B. B6 wild-type mice and perf  gzmA  B/
knockout mice were infected with FV. At 10 days postinfection, live, nucleated cells were stained with anti-CD8 antibody and anti-CD43 antibody to detect
effector T-cells (B). In addition, cells were also stained with anti-CD8 antibody and DbGagL tetramers to visualize FV-specific CD8+ T-cells (A). The
background staining with tetramers for uninfected mice (wt n.i.) was always between 0.5% and 1%. Dead cells were excluded by TOPRO-3 staining. Each dot
represents the results from a single mouse. The mean value for each group is indicated by a bar.
Fig. 2. Acute Friend virus infection in mouse strains deficient for perf, gzmA, gzmB, Fas, and/or FasL. C57BL/6 wild-type mice and knockout mice that lack
different cytotoxic molecules were infected with FV. Ten days postinfection, the mice were sacrificed and analyzed for disease progression and viral loads. The
results for the indicated knockout mice were compared with those from wild-type animals. Virus-induced disease was documented by spleen weights (A) and
the percentage of Ter119-positive erythroid precursor cells in the spleen (B). Viral loads were measured in the blood (C) and in the spleen (D) of infected mice.
Each dot represents the results from a single mouse. The mean value for each group is indicated by a bar. Differences between the group of infected wild-type
mice and the groups of knockout mice were compared by one-way analysis of variance using Dunnett’s multiple-comparison correction for comparing a control
group to several experimental groups. Significant differences are given in the figure.
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and proliferation of specific CTL was enhanced rather than
suppressed in perf  gzmA  B/ mice.
To address whether the lack of antiviral activity in perf 
gzmA  B/ mice was due to the deficiency in perf,
gzmA, and gzmB or due to a secondary effect on other
antiviral effector molecules like TNFa, IFNg, FasL, or Fas,
we compared the mRNA expression levels of CD8+ T-cells
between wt B6 and triple knockout mice during acute FV
infection. The results of the real time PCR analysis indicated
that the expression levels of TNFa, IFNg, Fas, and FasL
mRNA were comparable in the two different mouse strains
(data not shown). Thus, the susceptible phenotype of the
perf  gzmA  B/ knockout mice was only associated
with the lack of molecules from the exocytosis pathway.
Cytotoxicity of ex vivo CTLs from FV-infected B6 mice
In order to assess the cytolytic potential of CTL
generated during FV infection, spleen cells from B6 mice
taken at 14 days postinfection were tested for specific
cytolytic activity on FBL-3 target cells. These cells are
known to be sensitive to FV-specific and H-2Db restricted
CTL activity in vitro (Dittmer et al., 1999). Nevertheless,
no FV-specific cytolytic activity was detected (data not
shown). Consequently, a kinetic analysis of antigen-
independent cytolytic activity was performed in which
spleen cells from infected B6 mice were tested in a
redirected cytotoxicity assay on CD3-labelled P815 target
cells (Fig. 4). The cytolytic activity was mainly detected
between 7 and 18 days postinfection, with subsequent
decline to background levels. Therefore, we analyzed the
virus-specific cytolytic activity of splenocytes from FV-
infected B6 mice at 7 days postinfection, but again no
specific cytolytic activity was found (data not shown). A
comparative analysis of redirected CTL activity generated
in the course of FV versus LCMV infection of B6 mice,
the latter of which is known to lead to high frequencies of
CTL (Moskophidis et al., 1987), revealed an eightfold
higher cytotoxic potential of CTL in LCMV as comparedFig. 4. Ex vivo cytolytic T-cell activity during acute Friend virus infection. Re
analyzed at different time points postinfection. P815 target cells were labeled wit
symbols). After incubation of the target cells with effector cells from infected mito FV infection (data not shown). This indicates that the
numbers of spleen cells with cytolytic potential generated
in B6 mice during acute FV infection is rather low and
cannot be detected in a classical chromium-release assay
in vitro.
Persistent FV infection of knockout mice lacking different
cytotoxic molecules
B6 wt mice are resistant to FV-induced leukemia but
become persistently infected for life (Hasenkrug, 1999).
However, the immune system of B6 mice is able to
control persistent virus without any clinical symptoms,
and T-cells have been shown to be critical in keeping
persistent FV in check (Hasenkrug, 1999). To determine
whether the control of persistent virus is lost in knockout
mice, mutant mice of the different strains were infected
with FV and their spleen weights and spleen virus loads
were compared to B6 wt mice at 6 weeks postinfection.
Since perf  gzmA  B/ mice were unable to
suppress acute FV replication, they had high spleen virus
loads and progressed to leukemia at this later time point
(Figs. 5A and B). Due to their acute leukemia, no typical
chronic infection was established and all animals had to
be sacrificed at 6 weeks postinfection because of severe
clinical symptoms. In contrast, B6 wt mice and the
mutant mice lacking either perf alone, perf, and one of
the two gzms or both gzms had maintained immuno-
logical control over spleen virus replication and were not
spleneomegalic (Figs. 5A and 5B). However, animals
with deficiencies in the Fas pathway did not control
persistent FV as efficient as B6 wt mice. At 6 weeks
postinfection, gld mice (FasL mutant) developed a
moderate splenomegaly and their mean spleen virus load
was about 100-fold higher than that in B6 wt mice.
Furthermore, Fas/ mice lacking the Fas receptor also
harbored significantly more persistent virus in their
spleens compared to B6 mice. However, the enhanced
viral replication did not result in FV-induced erythroleu-
kemia at 6 weeks postinfection since the number ofdirected cytolytic activity of splenocytes from two FV-infected mice was
h anti-CD3 antibodies (filled symbols) or used unlabeled as controls (open
ce, the redirected lysis was measured via 51Cr-release assay.
Fig. 5. Persistent Friend virus infection in mouse strains deficient for perf, gzmA, gzmB, Fas, and/or FasL. C57BL/6 wild-type mice and knockout mice that
lack different cytotoxic molecules were infected with FV. Six weeks postinfection, the mice were sacrificed and analyzed for disease progression and viral
loads. The results for the indicated knockout mice were compared with those from wild-type animals. Virus-induced disease was documented by spleen
weights (A). Spleen weights of infected Fas/ and gld mice had to be compared to age-matched uninfected controls (not infected = n.i.) of the same strain,
since Fas/ and gld mice developed a progressing splenomegaly without any infection (Roths et al., 1984). Viral loads were measured in the spleen of
infected mice (B). Each dot represents the results from a single mouse. The mean value for each group is indicated by a bar. Differences between the group of
wild-type mice and the groups of knockout mice were compared by one-way analysis of variance using Dunnett’s multiple-comparison correction. Significant
differences are given in the figure.
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Fas/ mice and gld mice compared to naRve knockout
animals (data not shown). The data show that the Fas
pathway played a significant role in controlling chronic
retroviral infection.Discussion
Onset of disease during retroviral infections often
correlates with a loss of the antiviral CTL activity
(McMichael and Rowland-Jones, 2001; Migueles et al.,
2002; Rowland-Jones et al., 2001). In HIV-infected humans
the impaired ability of CTL to kill retrovirus-infected cells
was associated with low perf levels in CD8+ T-cells (Appay
et al., 2000). In addition, perf knockout mice have been
shown to be susceptible to mouse AIDS, which is induced
by the LP-BM5 mixture of murine retroviruses (Tang et al.,
1997). We now report that not only perf but also gzm A/B
and Fas/FasL can be involved in the control of retrovirus
spread by cytotoxic cells.
In numerous infection models with nonretroviruses, it has
been shown that perf alone or in combination with Fas/FasL
(Balkow et al., 2001; Ka¨gi et al., 1994b; Rode and Simon,
personal communication) or gzm (Mu¨llbacher et al., 1996,
1999; Riera et al., 2000) was sufficient for the control of
virus replication. In contrast, in none of these in vivo studies,
gzm alone were able to reduce viral loads in the absence of
perf. However, our experiments clearly show that in the
presence of functional active Fas/FasL the effector molecules
perf (gzmA  B/ mouse), gzmA (perf  gzmB/
mouse), or gzmB (perf  gzmA/ mouse) can independ-
ently control FV infection. Only mice lacking all three
molecules of the exocytosis pathway (perf  gzmA  B/mouse) had high viral loads and developed FV-induced
erythroleukemia (Fig. 2).
The finding that gzmA and gzmB alone mediated an
antiviral effect in FV infection was quite surprising and
raised the question of how these molecules are functionally
active without perf. It has been shown before that gzms can
get into a cell independently of perf by a receptor-mediated
pathway and are contained in endocytic vesicles. Perf is
critical for the release of enzymatically active gzms from the
vesicles to the cytoplasm (Jans et al., 1996, 1998; Metkar et
al., 2002; Pinkoski et al., 1998; Shi et al., 1997). According
to this model, gzm are nonoperative in the absence perf.
However, an alternative activation of gzms has been
described by Froelich et al., showing that proteins from a
nonreplicating adenovirus can replace the function of perf
by delivering gzm to the cytosol resulting in apoptosis of the
target cell (Froelich et al., 1996, 1998). A similar
mechanism might be involved in the antiviral activity of
gzms in FV infection. Furthermore, it is possible that gzms
have a direct effect on FV replication. In fact, it has been
reported for vesicular stomatitis virus that gzmB alone
decreased virus production in infected target cells through a
mechanism that degrades viral and host RNA (Hommel-
Berrey et al., 1997). Furthermore, in vitro studies with
Moloney murine leukemia virus indicate that gzmA can
cleave and inactivate the reverse transcriptase of retrovi-
ruses, a viral enzyme that is essential for virus replication, in
vitro (Simon et al., 1987). Since Moloney murine leukemia
virus and FV are genetically highly related viruses, the
published in vitro findings and our current in vivo data on
the antiviral activity of gzmA against retroviruses correlate
nicely. Thus, the effector mechanisms of the exocytosis
pathway seem to be broader in retroviral infections than
what was known before for other viruses.
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during acute retroviral infections, the Fas/FasL molecules
were dispensable for the control of early FV replication.
However, during persistent infection, Fas/FasL was required
for the resistance phenotype of the B6 mice. One possible
explanation for these contradictory findings is that different
subpopulations of T-cells are involved in the control of
acute versus persistent FV infections. Whereas CD8+ T-cells
are critical effector cells during acute infection they loose
their function during chronic infection with FV (Dittmer et
al., 2004; Hasenkrug et al., 1998a). Persistently infected
mice can be depleted for their CD8+ T-cells with no
consequences for viral loads or disease progression.
However, CD4+ T-cell depletion in chronically infected
mice leads to an increase in viral loads and progression to
lethal leukemia in most of the animals (Hasenkrug et al.,
1998a). Along these lines, it has been shown that CD4+ T-
cells with direct cytotoxic activity rather than CD8+ T-cells
control persistent FV infection (Iwashiro et al., 2001). In
other infection models, cytolytic CD4+ T-cells have been
reported to induce killing of target cells mainly by the Fas/
FasL apoptosis pathway (Zajac et al., 1996). Our current
results imply that the antiviral CD4+ T-cells that control
chronic FV infection also mediate their effect via Fas/FasL
molecules.
The Friend virus model provides the unique possibility to
define the cytotoxic cells and molecules that are involved in
the immune defense during acute and persistent retroviral
infections. We found a surprising redundancy of the
cytoplasmic granula molecules gzmA, gzmB, and perf as
antiviral agents during acute FV infection. In addition, the
current data suggest that acute and chronic retroviral
infections are controlled by distinct cytolytic mechanisms.
Such basic findings might help to better understand the
molecular interaction between cytolytic cells and human
retroviruses, like HIV or HTLV.Materials and methods
Mice
Inbred C57BL/6 (B6) and gld (Roths et al., 1984) mice as
well as mouse strains deficient for perforin (perf/) (Ka¨gi et
al., 1994a), perforin  granzyme A (perfgzmA/),
perforin  granzyme B (perf  gzmB/) (Mu¨llbacher et
al., 1999; Simon et al., 2000), granzyme A  B (gzmA 
B/) (Simon et al., 1997), and perforin  granzyme A  B
(perf  A  B/) were maintained at the Max-Planck-
Institut fqr Immunbiologie, Freiburg, Germany, under
pathogen-free conditions. All single knockout mice, except
gzmB/ (C57BL/6  129) (Heusel et al., 1994), are
originated from B6 ES cells. The gzmB/ mice were bred
onto the B6 background (eight backcrosses). Fas-deficient
mice (Fas/) were generated in Dr. Nagata’s lab (Adachi et
al., 1995) and were kindly provided by M. Klein (Zqrich,Switzerland). In all experiments, 3- to 6-month-old mice
were used.
Cells and cell culture
FBL-3 (H2Db-positive, FV-transformed tumor cells)
(Greenberg, 1991) and P815 (H2d; FcR expressing masto-
cytoma-) cells were maintained in complete MEM medium
(10% FCS; 105 M 2-ME) as described (Simon et al.,
1997). Both cell lines were used as target cells in the
cytotoxicity assays.
Virus infection
In all virus infection experiments, mice were injected
intravenously with 0.5 ml PBBS containing 12500 spleen
focus forming units (SFFU) of Friend virus complex. The
B-tropic, polycythemia-inducing FV complex used in all
experiments was from uncloned virus stocks obtained from
10% spleen cell homogenates as described (Hasenkrug et
al., 1998b). Between 1 and 6 weeks postinfection, mice
were sacrificed and their spleen weights were determined to
study disease progression.
For ex vivo studies, mice were infected intraperitoneal
(ip) with 105 plaque-forming units (pfu) of LCMV, strain
WE, according to established protocols (Balkow et al.,
2001).
Infectious center assays
Titrations of single cell suspensions from infected mouse
spleens were plated onto susceptible Mus dunni cells
(Lander and Chattopadhyay, 1984), cocultivated for 3 days,
fixed with ethanol, stained with F-MuLV envelope-specific
mAb 720 (Robertson et al., 1991), and developed with
peroxidase-conjugated goat anti-mouse antibodies and AEC
to detect foci.
Flow cytometric analysis for F-MuLV antigen expression
Single cell suspensions were analyzed using a Becton
Dickinson FACSCalibur flow cytometer. Cells were stained
with hybridoma cell supernatant containing monoclonal
antibody 34 (Chesebro et al., 1981), which is specific for F-
MuLV glycogag protein expressed on the surfaces of
infected cells. Development was done with FITC-labeled
goat anti-mouse IgG2b-specific antiserum (Caltag Labora-
tories, Burlingame, CA) preabsorbed with mouse cells to
remove background activity (109 nucleated spleen cells/ml
serum, 40 min on ice).
Lymphocyte depletion
CD8+ T-cell depletions were performed essentially as
described (Hasenkrug et al., 1998a). Briefly, mice were
inoculated ip with 0.5 ml of supernatant fluid obtained from
G. Zelinskyy et al. / Virology 330 (2004) 365–374372hybridoma cell culture for the CD8-specific monoclonal
antibody 169.4. Mice were inoculated every other day for
four times starting on the day of FV infection. The treatment
depleted 83% of CD8+ cells in the spleen of the respected
mice (measured at 10 days post-FV infection). For flow
cytometry analysis of depletions, cell populations were
stained with anti-CD8a monoclonal antibody 5H19 (Caltag,
Hamburg, Germany).
Tetramer staining
For detection of activated virus-specific CD8+ T-cells,
5  105 nucleated spleen cells were stained with anti-CD8,
anti-CD43 (Pharmingen, Heidelberg, Germany), and PE-
labeled MHC class I H-2Db tetramer specific for the
immunodominant GagL CTL epitope gPr80gag85-93 (Chen
et al., 1996) for 15 min at room temperature. The tetramers
contained modified versions of the Gag epitope in which all
three cysteine residues were replaced with aminobutyric
acid (Schepers et al., 2002). After washing, cells were
analyzed by flow cytometry. Dead cells were excluded by
TOPRO-3 (Molecular Probes, Leiden, The Netherlands)
staining.
Cytotoxicity assay
The 51Cr-release assay (cytolysis) was performed for 5 h,
essentially as described (Simon et al., 2000; Ebnet et al.,
1995). After the indicated time periods, 30 Al of supernatant
was harvested onto a solid scintillator plate (LumaPlate,
Packard, Dreieich, Germany), dried and counted with
TopCount (Packard). Percentage of specific cytolysis or
nucleolysis was calculated by the formula: % specific lysis =
[(experimental release  medium release)/(maximum
release (2% Triton X)  medium release)]  100. Data
given are the means of triplicate determinations. SEM
values were always b 5%.
The redirected cytolysis was performed by using Fc-
receptor-expressing P815 target cells, which were labeled
with 2 Ag/ml hamster anti-mouse CD3-E antibody (145-
2C11; purified from culture supernatants by protein
sepharose column chromatography). Labeled target cells
bind T-cells via the anti-CD3 antibody and are subsequently
lysed by activated effector cells. For the detection of the FV-
specific cytolysis, FBL-3 cells were used as target cells.
These cells have been described to be sensitive to CTL-
mediated killing by FV-specific T-cells (Dittmer et al.,
1999).
Effector cells
For the in vitro cytotoxicity assays, primary FV- or
LCMV-immune splenocytes were used at 7 days post-
infection. In experiments in which FV-specific cytotoxic
activity was analyzed, isolated CD8+ lymphocytes were
used. Therefore, the splenocytes were washed in PBS/5%FCS and stained with CD8-MicroBeads (Miltenyi Biotec,
Bergisch Gladbach, Germany) according to manufacturers
instructions. CD8+ cells were positively selected with an
auto MACS (Miltenyi Biotec), washed and resuspended in
MEM/2 mg/ml BSA prior to use in cytotoxic assays. Purity
was assessed by FACS staining with CD8-FITC (clone 53-
6.7, Pharmingen) and found to be between 90% and 98%.Acknowledgments
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